Literature DB >> 16470354

[Sequelae of organ transplantation].

S Ciesek1, M Manns, C Strassburg.   

Abstract

Transplant medicine has significantly changed the prognosis of diseases leading to terminal organ failure. It has evolved from an experimental procedure to standard therapy for liver, kidney and cardio-vascular diseases. Transplant medicine combines operative organ replacement with the management of severely ill patients before transplantation, as well as life-long follow-up of organ graft recipients. Ten year survival rates of 65% to over 90% have led to a steady increase of transplanted patients seen by general medical care providers which represents a challenge for practicing internists. Apart from organ-specific conditions, infectious, immunosuppressant-associated and metabolic consequences determine long-term survival. These include virus reactivation, graft rejection, anastomotic problems but more importantly general mortality determining factors such as diabetes, renal insufficiency and hypertension, which are often a consequence of immunosuppressant administration. They directly impact long-term survival. The awareness and treatment of these secondary conditions of organ transplantation in routine medical practice contributes significantly to secure the long term success of transplant medicine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470354     DOI: 10.1007/s00108-006-1583-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

Review 1.  Biliary complications of orthotopic liver transplantation.

Authors:  B Y Tung; M B Kimmey
Journal:  Dig Dis       Date:  1999       Impact factor: 2.404

2.  New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view.

Authors:  Jaime A Davidson; Alan Wilkinson
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

Review 3.  What determines the natural history of recurrent hepatitis C after liver transplantation?

Authors:  Marina Berenguer
Journal:  J Hepatol       Date:  2005-04       Impact factor: 25.083

4.  Long-term survival after liver transplantation.

Authors:  F C Ryckman; M H Alonso; J C Bucuvalas; W F Balistreri
Journal:  J Pediatr Surg       Date:  1999-05       Impact factor: 2.545

5.  Endoscopic management of biliary complications after orthotopic liver transplantation.

Authors:  R E Hintze; A Adler; W Veltzke; H Abou-Rebyeh; R Felix; P Neuhaus
Journal:  Hepatogastroenterology       Date:  1997 Jan-Feb

Review 6.  New-onset diabetes after transplantation.

Authors:  Martha Pavlakis
Journal:  Curr Diab Rep       Date:  2005-08       Impact factor: 4.810

Review 7.  Management of hepatitis B in liver transplantation patients.

Authors:  Didier Samuel
Journal:  Semin Liver Dis       Date:  2004       Impact factor: 6.115

8.  Prediction of lung-transplant rejection by hepatocyte growth factor.

Authors:  Seyedhossein Aharinejad; Shahrokh Taghavi; Walter Klepetko; Dietmar Abraham
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

Review 9.  Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients.

Authors:  Anders Asberg
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Hypertension after kidney transplantation: impact, pathogenesis and therapy.

Authors:  Rubin Zhang; Bruce Leslie; J Philip Boudreaux; Daniel Frey; Efrain Reisin
Journal:  Am J Med Sci       Date:  2003-04       Impact factor: 2.378

View more
  2 in total

Review 1.  [Liver transplantation: indications and results].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

2.  Dyadic Coping of Kidney Transplant Recipients and Their Partners: Sex and Role Differences.

Authors:  Daria Tkachenko; Laura Franke; Luisa Peters; Mario Schiffer; Tanja Zimmermann
Journal:  Front Psychol       Date:  2019-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.